
ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data
10/11/2026
0:00
1:47
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.
Otros episodios de "Applied Clinical Trials"



No te pierdas ningún episodio de “Applied Clinical Trials”. Síguelo en la aplicación gratuita de GetPodcast.








